"Snapdragon is pleased to announce a major strategic investment from Asymchem. The combination of Snapdragon's technology and process development capabilities, along with Asymchem's expertise in clinical and commercial manufacturing will provide our clients with a complete solution to drug development."
View the whole press release below:
